322 related articles for article (PubMed ID: 20674792)
1. Common and emerging fungal pulmonary infections.
Hsu LY; Ng ES; Koh LP
Infect Dis Clin North Am; 2010 Sep; 24(3):557-77. PubMed ID: 20674792
[TBL] [Abstract][Full Text] [Related]
2. Antifungal prophylaxis in lung transplantation.
Avery RK
Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
[TBL] [Abstract][Full Text] [Related]
3. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
4. Management of fungal lung disease in the immunocompromised.
Islam A; Mody CH
Ther Adv Respir Dis; 2011 Oct; 5(5):305-24. PubMed ID: 21807757
[TBL] [Abstract][Full Text] [Related]
5. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.
Jacobs SE; Wengenack NL; Walsh TJ
Semin Respir Crit Care Med; 2020 Feb; 41(1):115-130. PubMed ID: 32000288
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
7. Rare and emerging fungal pulmonary infections.
Varkey JB; Perfect JR
Semin Respir Crit Care Med; 2008 Apr; 29(2):121-31. PubMed ID: 18365994
[TBL] [Abstract][Full Text] [Related]
8. Fungi and molds following lung transplantation.
Hosseini-Moghaddam SM; Husain S
Semin Respir Crit Care Med; 2010 Apr; 31(2):222-33. PubMed ID: 20354934
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
10. Emerging moulds: epidemiological trends and antifungal resistance.
Miceli MH; Lee SA
Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
[TBL] [Abstract][Full Text] [Related]
11. Emerging fungal pathogens in pulmonary disease.
Sanchez A; Larsen R
Curr Opin Pulm Med; 2007 May; 13(3):199-204. PubMed ID: 17414127
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary fungal infections.
Smith JA; Kauffman CA
Respirology; 2012 Aug; 17(6):913-26. PubMed ID: 22335254
[TBL] [Abstract][Full Text] [Related]
13. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
Solé A
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
15. Non-Aspergillus fungal pneumonia in transplant recipients.
Costa SF; Alexander BD
Clin Chest Med; 2005 Dec; 26(4):675-90, vii. PubMed ID: 16263405
[TBL] [Abstract][Full Text] [Related]
16. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections after lung transplantation.
Solé A; Salavert M
Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
[TBL] [Abstract][Full Text] [Related]
18. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
[TBL] [Abstract][Full Text] [Related]
19. [Invasive fungal infection in immunocompromised patients].
García-Ruiz JC; Amutio E; Pontón J
Rev Iberoam Micol; 2004 Jun; 21(2):55-62. PubMed ID: 15538828
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
Camps IR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
